These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 31825461)

  • 1. Regulated resurfacing of a somatostatin receptor storage compartment fine-tunes pituitary secretion.
    Alshafie W; Francis V; Bednarz K; Pan YE; Stroh T; McPherson PS
    J Cell Biol; 2020 Jan; 219(1):. PubMed ID: 31825461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of somatostatin receptor subtypes in membrane ion channel modification by somatostatin in pituitary somatotropes.
    Yang SK; Chen C
    Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1221-7. PubMed ID: 17892506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin receptor subtype specificity in human fetal pituitary cultures. Differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone, and prolactin regulation.
    Shimon I; Taylor JE; Dong JZ; Bitonte RA; Kim S; Morgan B; Coy DH; Culler MD; Melmed S
    J Clin Invest; 1997 Feb; 99(4):789-98. PubMed ID: 9045884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin receptors in pituitary and development of somatostatin receptor subtype-selective analogs.
    Shimon I
    Endocrine; 2003 Apr; 20(3):265-9. PubMed ID: 12721506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional association of somatostatin receptor subtypes 2 and 5 in inhibiting human growth hormone secretion.
    Ren SG; Taylor J; Dong J; Yu R; Culler MD; Melmed S
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4239-45. PubMed ID: 12970293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the somatostatin receptor subtypes involved in regulation of growth hormone secretion in chickens.
    Bossis I; Porter TE
    Mol Cell Endocrinol; 2001 Sep; 182(2):203-13. PubMed ID: 11514055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of GHRH and GHRP-2 treatment in vitro on GH secretion and levels of GH, pituitary transcription factor-1, GHRH-receptor, GH-secretagogue-receptor and somatostatin receptor mRNAs in ovine pituitary cells.
    Yan M; Hernandez M; Xu R; Chen C
    Eur J Endocrinol; 2004 Feb; 150(2):235-42. PubMed ID: 14763922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oestrogen replacement in vivo rescues the dysfunction of pituitary somatotropes in ovariectomised aromatase knockout mice.
    Yan M; Jones ME; Hernandez M; Liu D; Simpson ER; Chen C
    Neuroendocrinology; 2005; 81(3):158-66. PubMed ID: 16015026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential involvement of signaling pathways in the regulation of growth hormone release by somatostatin and growth hormone-releasing hormone in orange-spotted grouper (Epinephelus coioides).
    Wang B; Qin C; Zhang C; Jia J; Sun C; Li W
    Mol Cell Endocrinol; 2014 Feb; 382(2):851-9. PubMed ID: 24183819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of somatostatin receptors controlling growth hormone and thyrotropin secretion in the chicken using receptor subtype-specific agonists.
    Geris KL; de Groef B; Rohrer SP; Geelissen S; Kühn ER; Darras VM
    J Endocrinol; 2003 May; 177(2):279-86. PubMed ID: 12740016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatostatin receptor (SSTR) subtype-selective analogues differentially suppress in vitro growth hormone and prolactin in human pituitary adenomas. Novel potential therapy for functional pituitary tumors.
    Shimon I; Yan X; Taylor JE; Weiss MH; Culler MD; Melmed S
    J Clin Invest; 1997 Nov; 100(9):2386-92. PubMed ID: 9410919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin receptor subtype 1 modulates basal inhibition of growth hormone release in somatotrophs.
    Kreienkamp HJ; Akgün E; Baumeister H; Meyerhof W; Richter D
    FEBS Lett; 1999 Dec; 462(3):464-6. PubMed ID: 10622746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of rat and human growth hormone and prolactin secretion by a novel somatostatin/dopaminergic chimeric ligand.
    Ren SG; Kim S; Taylor J; Dong J; Moreau JP; Culler MD; Melmed S
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5414-21. PubMed ID: 14602782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin receptor subtype 2 and 5 in human GH-secreting pituitary adenomas: analysis of gene sequence and mRNA expression.
    Corbetta S; Ballaré E; Mantovani G; Lania A; Losa M; Di Blasio AM; Spada A
    Eur J Clin Invest; 2001 Mar; 31(3):208-14. PubMed ID: 11264647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the intracellular mechanisms mediating somatostatin and lanreotide inhibition of DNA synthesis and growth hormone release from dispersed human GH-secreting pituitary adenoma cells in vitro.
    Florio T; Thellung S; Corsaro A; Bocca L; Arena S; Pattarozzi A; Villa V; Massa A; Diana F; Schettini D; Barbieri F; Ravetti JL; Spaziante R; Giusti M; Schettini G
    Clin Endocrinol (Oxf); 2003 Jul; 59(1):115-28. PubMed ID: 12807513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects of SOM230 on adrenocorticotropic hormone production and corticotroph tumor cell proliferation in vitro and in vivo.
    Murasawa S; Kageyama K; Sugiyama A; Ishigame N; Niioka K; Suda T; Daimon M
    Mol Cell Endocrinol; 2014 Aug; 394(1-2):37-46. PubMed ID: 25011056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BIM-23A760, a chimeric molecule directed towards somatostatin and dopamine receptors, vs universal somatostatin receptors ligands in GH-secreting pituitary adenomas partial responders to octreotide.
    Jaquet P; Gunz G; Saveanu A; Barlier A; Dufour H; Taylor J; Dong J; Kim S; Moreau JP; Culler MD
    J Endocrinol Invest; 2005; 28(11 Suppl International):21-7. PubMed ID: 16625841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin Receptor Expression in GH-Secreting Pituitary Adenomas Treated with Long-Acting Somatostatin Analogues in Combination with Pegvisomant.
    Franck SE; Gatto F; van der Lely AJ; Janssen JAMJL; Dallenga AHG; Nagtegaal AP; Hofland LJ; Neggers SJCMM
    Neuroendocrinology; 2017; 105(1):44-53. PubMed ID: 27455094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The growth hormone (GH)-axis of GH receptor/binding protein gene-disrupted and metallothionein-human GH-releasing hormone transgenic mice: hypothalamic neuropeptide and pituitary receptor expression in the absence and presence of GH feedback.
    Peng XD; Park S; Gadelha MR; Coschigano KT; Kopchick JJ; Frohman LA; Kineman RD
    Endocrinology; 2001 Mar; 142(3):1117-23. PubMed ID: 11181526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GH in the dwarf dopaminergic D2 receptor knockout mouse: somatotrope population, GH release, and responsiveness to GH-releasing factors and somatostatin.
    García-Tornadú I; Rubinstein M; Gaylinn BD; Hill D; Arany E; Low MJ; Díaz-Torga G; Becu-Villalobos D
    J Endocrinol; 2006 Sep; 190(3):611-9. PubMed ID: 17003262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.